Abstract 4347: Preclinical evaluation of pharmacokinetic interactions among nebivolol, dasatinib and devimistat in miceAirong Li, Mikayla Skillman, Fatima Dagher et al.|Cancer Research|2025Cited by 1
Abstract 3158: Pharmacokinetic and biodistribution evaluation of nebivolol and dasatinib in the 4T1 triple-negative breast cancer model: Implications for drug-drug interactionAirong Li, Diana S.-L. Chow, Emanuel Baltrip et al.|Cancer Research|2026Cited by 1
LC–MS/MS Assay for Simultaneous Quantification of Nebivolol, Dasatinib, and Devimistat and Its Application in RatsAirong Li, Diana S‐L Chow, Mikayla Skillman et al.|Separation Science Plus|2026Cited by 0